Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

A Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer

ClinicalTrials.gov ID: NCT03701334

Public ClinicalTrials.gov record NCT03701334. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 9:56 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Multi-center, Randomized, Open-label Trial to Evaluate Efficacy and Safety of Ribociclib With Endocrine Therapy as an Adjuvant Treatment in Patients With Hormone Receptor-positive, HER2-negative Early Breast Cancer (New Adjuvant TriAl With Ribociclib [LEE011]: NATALEE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A phase III, multicenter, randomized, open-label trial to evaluate the efficacy and safety of ribociclib with Endocrine Therapy (ET) as an adjuvant treatment in women and men with Hormone Receptor positive (HR+), Human Epidermal Growth Factor Receptor 2 negative (HER2-) Early Breast Cancer (EBC).

Study identification

NCT ID
NCT03701334
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
5,101 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 100 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 7, 2018 (Actual)
Primary completion
May 29, 2030 (Estimated)
Completion
May 29, 2030 (Estimated)
Last update posted
Oct 9, 2026

2018 – 2030

United States locations

U.S. sites
73
U.S. states
31
U.S. cities
71
Facility City State ZIP Site status
University of Alabama at Birmingham-Kirklin Clinic Birmingham Alabama 35294-0006 —
Cancer Treatment Centers of America Goodyear Arizona 85338 —
St Bernards Medical Center Jonesboro Arkansas 72401 —
Comprehensive Blood and Cancer Bakersfield California 93309 —
UCLA Beverly Hills Beverly Hills California 90212 —
UCLA Burbank Burbank California 91505 —
Encino Research Center Encino California 91436 —
St. Jude Heritage Medical Group Fullerton California 92835 —
UCLA Hematology Oncology Laguna Hills California 92653 —
Southern CA Oncology Rsrch Alliance Los Angeles California 90057 —
Stanford University Medical Center Palo Alto California 94304-1509 —
UCLA Pasadena HC Hemato Onco Pasadena California 91105 —
UCLA Porter Ranch Hemato and Onco Porter Ranch California 91326 —
Cancer Care Associates Medical Grp Redondo Beach California 90277 —
Sharp Memorial Hospital San Diego California 92123 —
UCSF San Francisco California 94115 —
Central Coast Medical Oncology Corporation Santa Maria California 93454 —
UCLA Santa Monica Hematology Oncology Santa Monica California 90404 —
Lundquist Inst BioMed at Harbor Torrance California 90509-2910 —
UCLA Valencia Valencia California 91355 —
Valley Breast Care Van Nuys California 91405 —
UCLA Cancer Center Westlake Village Westlake Village California 91361 —
University Of Colorado Hospital Aurora Colorado 80045 —
Rocky Mountain Cancer Centers Denver Colorado 80218 —
Hospital of Central Connecticut New Britain Connecticut 06052 —
Yale University School Of Medicine New Haven Connecticut 06520 —
Norwalk Hospital Norwalk Connecticut 06856 —
Eastern Connecticut Hematology and Oncology Associates Norwich Connecticut 06360 —
Holy Cross Hospital-Ft. Lauderdale Fort Lauderdale Florida 33308 —
Florida Cancer Specialists Fort Myers Florida 33901 —
Memorial Cancer Institute Hollywood Florida 33021 —
Baptist MD Anderson Cancer Center Jacksonville Florida 32207 —
University of Miami Miami Florida 33136 —
Orlando Health Clinical Trials Orlando Florida 32806 —
Florida Cancer Specialists-North St. Petersburg Florida 33705 —
Florida Cancer Specialists Pan Tallahassee Florida 32308 —
Florida Cancer Specialists West Palm Beach Florida 33401 —
Winship Cancer Institute of Emory University Atlanta Georgia 30322 —
Southeastern Regional Medical Center Newnan Georgia 30265 —
Cancer Treatment Centers of America Zion Illinois 60099 —
Cancer Care Center New Albany Indiana 47150 —
University of Kansas Cancer Center Westwood Kansas 66205 —
Cancer Center of Kansas Wichita Kansas 67214-3728 —
Norton Cancer Institute Louisville Kentucky 40202 —
Mercy Medical Center Baltimore Maryland 21202 —
Massachusetts General Hospital Boston Massachusetts 02114 —
University of Michigan Cancer Center Ann Arbor Michigan 48109 —
Fairview Health Services Maple Grove Minnesota 55369 —
Metro Minnesota CCOP Saint Louis Park Minnesota 55416 —
Park Nicollet Institute Saint Louis Park Minnesota 55416 —
Saint Lukes Hospital of Kansas City Kansas City Missouri 64111 —
HCA Midwest Division Kansas City Missouri 64132 —
David C Pratt Cancer Center St Louis Missouri 63141 —
St Vincent Frontier Cancer Center Billings Montana 59102 —
Saint Francis Medical Center Grand Island Nebraska 68803 —
Comprehensive Cancer Cntr Of Nevada Henderson Nevada 89052 —
Saint Barnabas Medical Center Livingston New Jersey 07039 —
Perlmutter Cancer Centre New York New York 10016 —
Randolph Medical Associates Asheboro North Carolina 27204 —
Cone Health Cancer Center Greensboro North Carolina 27403 —
Kaiser Permanente NW Region Clackamas Oregon 97015 —
Penn State Hershey Cancer Institute Hershey Pennsylvania 17033 —
Cancer Treatment Centers of America Eastern Regional Medical Center Philadelphia Pennsylvania 19124 —
The West Clinic Germantown Tennessee 38138 —
Sarah Cannon Research Institute Nashville Tennessee 37203 —
Baylor Charles A Sammons Cancer Cnt Dallas Texas 75246 —
Ctr For Cancer And Blood Disorders Fort Worth Texas 76104 —
MD Anderson Cancer Center University of Texas Houston Texas 77030 —
Utah Cancer Specialists Salt Lake City Utah 84106 —
Virginia Cancer Specialists Fairfax Virginia 22031 —
Virginia Cancer Institute Richmond Virginia 23230 —
Fred Hutchinson Cancer Center Seattle Washington 98109 —
University of Wisconsin Paul P Carbone Comp Cancer Center Madison Wisconsin 53792-6164 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 314 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03701334, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 9, 2026 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03701334 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →